Proliferation of mesangial cells and expansion of mesangial matrix is a hallmark of glomerular disease leading to end-stage renal failure and requiring renal replacement therapy. Independently from the type of injury, e.g. in glomerulonephritis or diabetic nephropathy, the response to injury is remarkably uniform. Chronic glomerular disease is frequently associated with increases in systemic blood pressure and altered intraglomerular hemodynamics. Furthermore, reduction of systemic blood pressure and inhibition of the vasoconstrictor peptide angiotensin II have been shown to delay end-stage renal failure in various types of human kidney disease. Since vasoconstrictors of mesangial cells and efferent glomerular arterioli, such as angiotensin II, are thought to be detrimental for the progression of chronic glomerular disease, we propose that vasodilatory factors which antagonize the effects of angiotensin II, might have beneficial effects during the course of progressive kidney disease. To support this concept we will summarize currently available data on the role of vasodilatory signaling molecules such as natriuretic peptides (ANP, BNP and CNP), nitric oxide (NO), the prostaglandines PGE2 and prostacycline, and the purine mediator adenosine in the regulation of mesangial function.
Introduction
As part of the glomerular response to injury, mesangial cells undergo cell replication and increased production of The majority of cases with end-stage renal failure is due extracellular matrix [2-4]. These processes have been to glomerular disease resulting either from diabetes melshown to impair glomerular ultrafiltration finally resulting litus or glomerulonephritis [1] . In these conditions, metain glomerular sclerosis and end-stage renal failure. Bebolic or immunologic injury causes damage of the cause mesangial cells are critical involved in glomerular glomerulus which is a specialized structure in the kidney disease, much effort has been made to analyze mesangial serving to generate approximately 170 liters ultrafiltrate cell function in normal conditions as well as in glomerular from the circulating plasma [1] . The glomerulus is built by disease. To study the role of mesangial cell during four cell types: endothelial cells outlining the glomerular progression of glomerular disease, cell culture of mesangicapillaries, mesangial cells functioning as pericytes adjaal cells was extensively used over the last 20 years [2-4]. cent to the glomerular capillary, visceral glomerular epiIn addition, studies in experimental animals and human thelial cells or podocytes attached to glomerular basement disease were used to examine the role of various factors membrane, and parietal glomerular epithelial cells coverwhich were thought to regulate mesangial cell function. ing the inner surface of Bowman's capsule [1] . Among Using these techniques, multiple cytokines, vasoactive these cell types glomerular mesangial cells are critical peptides and autacoids were identified which stimulate involved during various types of glomerular injury [2] [3] [4] .
mesangial cell proliferation as well as deposition of extracellular matrix within the glomerulus [1-4]. As detrimental factors these studies identified e.g. angiotensin Receptors detectable in  Type A, B, C  EP-1, EP-2,  -A-1, A-2  cultured mesangial cells  EP-3, EP-4 Signal transduction cGMP ↑,
Abbreviations: BKCa (Ca -activated K -channels), IP3 (inositol trisphosphate) MAP-K (mitogen-activated-protein kinase), MKP-1 (mitogenactivated phosphatase-1), JNK (c-Jun NH2-terminal kinase), SAPK (stress-activated protein kinase).
II, TGF-beta and PDGF to name only a few. Much less express 12 000 ANP receptors per cell on the surface. factors were identified which counteract the detrimental Interestingly, the number of ANP receptors on the cell effects of these molecules [1-4]. Since natriuretic peptides, surface was increased by a low-sodium diet for 2 weeks, nitric oxide, vasodilatory prostaglandines and adenosine while a high sodium diet resulted in a decrease of receptor antagonize some effects of detrimental mediators such as density [8] . The type-B receptor is expressed in the adrenal angiotensin II, these vasodilatory signaling molecules may gland, the kidney and the brain. Cultured mesangial cells be potential therapeutic substances in progressive glomeruhave been shown to predominantly express type-B natlar disease. Current information on the vasodilatory sigriuretic peptide receptors but also type A and C receptors naling molecules and their regulatory role on mesangial [9] . Activation of type-A and type-B receptors by natcell function is summarized in this review (Table 1) .
riuretic peptides results in an activation of the cGMP signaling cascade which mediates the effects of natriuretic peptides. Type-C receptors for natriuretic peptides are 2. Natriuretic peptides thought to be involved in degradation of natriuretic peptides. After binding of natriuretic peptides to this The natriuretic peptides include atrial natriuretic peptide receptor the peptide is internalized into the cell and (ANP), brain natriuretic peptide (BNP) and C-type natdegraded by proteolytic enzymes. The receptor is subriuretic peptide (CNP). These different peptides are ensequently recycled to the cell surface for a new cycle of coded by separate genes which are regulated independently binding and re-endocytosis of natriuretic peptides [10] . In and exhibit specific tissue distribution. ANP is predomigastrointestinal smooth muscle cells type-C receptor is nantly synthesized in atrial tissue of the heart. The full coupled to activation of phospholipase C-beta 3 via Gpeptide of ANP is a 126 amino-acids polypeptide chain. In proteins and to inhibition of adenylyl cyclase [11] . the kidney the propeptide is cleaved in a 32 amino-acids Since proliferation of mesangial cells is a hallmark of peptide called urodilatin (CDD/ANP-95-126) which is glomerular disease, the effect of ANP on mesangial cells important for the regulation of volume and electrolytes [5] .
has been examined in several studies (Table 1) . While Another cleavage product called cardiodilatin (CDD/ANPplasma concentrations of ANP in rats and humans are in 99-126) generated in cardiac tissue is involved in blood the picomolar range [12] , micro to nanomolar concenpressure regulation [6] . The second natriuretic peptide, trations were required to produce activation of signal BNP, is a 32 amino-acids peptide which is generated from transduction pathways and phenotypic changes in cultured the propeptide by proteolytic cleavage. There are two cells, i.e. in rat mesangial cells [13] . In cell culture ANP active peptides derived from pro-CNP: the larger 53 has been shown to inhibit the proliferation of rat mesangial amino-acids peptide and a smaller 22 amino-acids peptide.
cells as judged by 3H-thymidine uptake [14, 15] . This Three different receptors recognizing natriuretic peptides effect was reproduced by addition of cyclic GMP analogue have been identified. The type-A receptor has been found which indicates that ANP induced growth reduction is to bind ANP and -with lower affinity-BNP. The type-B caused by an increase in intracellular cyclic GMP [16] . receptor is specific for CNP [7] . The type-A receptor is Inhibition of mesangial cell proliferation by ANP is found in larger blood vessels, adrenal glands and in the partially due to increased expression of mitogen-activatedkidney. Cultured rat mesangial cells have been shown to phosphatase (MKP-1). ANP and cyclic GMP analogues have been shown to cause increased expression of MKP-1. Intracellular pH has been shown to be involved in the MKP-1 is a negative regulator of mitogen-activatedcomplex processes leading to cell replication. The nat-
protein-kinase (MAPK) which is a major mitogenic sigriuretic peptides inhibit the Na / H exchanger in naling molecule [17] . It has been shown that MAP-kinase mesangial cells which impairs pH-regulation in these cells. activity induced by angiotensin II, endothelin I, PDGF and
The effect is dependent on cyclic GMP and inhibited by a FGF is inhibited by ANP. As an example endothelin-1 protein kinase G-inhibitor [32] . activates the mitogen-activated protein kinases extracllular Similar to ANP the natriuretic peptide CNP has been signal-regulated kinase (ERK) and c-Jun NH2-terminal shown to be antimitogenic for cultured mesangial cells. kinase (JNK) associated with mesangial cell proliferation.
Injection of CNP into rats caused a significant reduction of ANP and BNP inhibited ET-1-induced activation of ERK mesangial cell proliferation in mesangioproliferative gloand JNK in a dose-dependent manner [18] [19] [20] . Addition of merulonephritis in rats. Furthermore, deposition of col-HS-142-1 reverses the antimitogenic effect of ANP, inlagen type IV and fibronectin was reduced in this model dicating that the ANP effect is mediated by specific ANP [33] . Similarly, mice overexpressing brain natriuretic receptors [21] . The inhibitory effect of ANP is even peptide (BNP) exhibit ameliorated glomerular injury in a stronger and reaches 70% inhibition if the type-A receptor model of focal glomerular sclerosis [34] . of natriuretic peptides is overexpressed. Direct transfection of ANP in these cells causes not more than 20% inhibition. The effect was reversed by addition of an inhibitor of 3. Nitric oxide cGMP dependent protein kinase [22] . Furthermore, ANP has been shown to inhibit mesangial cell contraction
Since the discovery of nitric oxide (NO) as endothelial induced by angiotensin II [23] . Kohno et al. demonstrated derived relaxing factor (EDRF) in the late 1980s, the role that ANP and BNP inhibited the migration of mesangial of NO in renal, glomerular and mesangial function was cells through a cGMP-dependent mechanism [24] .
extensively studied [35] . NO is a small, short lived In addition to activation of MKP-1, ANP may inhibit molecule which is produced from L-arginine by a family of mitogenesis of mesangial cells by upregulation of the enzymes called NO synthases [36] . The type-1 NO synthanti-mitogenic factor TGF-beta. Increased expression of ase is found in neuronal cells of the brain and the macula TGF-beta is due to increase in cyclic GMP after stimuladensa of the kidney where NO is thought to play a role in tion with ANP. The anti-mitogenic effect of ANP is tubuloglomerular feedback [37] . The inducible form of NO partially reversed by addition of neutralizing anti-TGF-beta synthase (type-2 enzyme) is found in macrophages and antibodies [25] . Since ANP induces TGF-beta in cultured glomerular mesangial cells. It is induced by bacterial mesangial cells, ANP may increase matrix deposition in endotoxin and cytokines (e.g. TNF-alpha, interleukin-1-the mesangium.
beta, interferon-gamma). This isoform has been described In cultured rat mesangial cells ANP reduces the increase to produce NO at much higher concentrations than the 11 of intracellular Ca by a cyclic GMP-dependent mechaother isoforms. Isoform three of NO synthase is constitu-11 nism [26] . Ca is an important cation involved in many tively expressed in endothelial cells throughout the body.
11
cellular functions. Ca binds to a number of proteins and NO has been shown to activate soluble guanylyl cyclase thereby regulates the structural integrity of cells, their which results in a strong increase in intracellular cyclic contractility and the production of inflammatory mediators.
GMP formation in glomerular disease. NO production has
The effect of ANP on intracellular Ca is dependent on been shown to be greatly increased in the glomerulus [38] . cell density. An increase in cell density results in a Infiltrating macrophages stimulated by cytokines are 11 pronounced decrease in intracellular Ca [26] . In addithought to contribute to strong NO production found in this 11 tion it has been shown that release of intracellular Ca by condition. Narita et al. proposed that high levels of NO angiotensin II is inhibited by ANP [27] . It is thought that may even mediate immunologic injury to kidney mesan-11 the effect of ANP on intracellular Ca concentrations gium in experimental glomerulonephritis [39] . By contrast, plays an important role in ANP mediated vasodilatation endogenously synthesized NO has been shown to prevent [28] .
endotoxin induced glomerular thrombosis [40] . Recently,
ANP has been shown to activate large Ca -activated expression of the three isoforms of NO synthase was 1 K -channels (BKCa) via formation of cGMP and a cGMPstudied in renal tissue of patients with different types of dependent protein kinase in rat mesangial cells. BKCa glomerulonephritis. Inducible NO synthase was localized appears to play an important role in counteracting the in mesangial cells, glomerular epithelial cells and infiltratangiotensin II induced contraction of mesangial cells.
ing macrophages in the diseased glomeruli, whereas imAngiotensin II causes a depolarization of the membrane by munostaining was hardly detected in normal human kid- Ca influx by supporting repolarization of the plasma control and diseased kidney. The extent of staining for membrane [29] [30] [31] .
endothelial NO synthase correlated negatively with the degree of glomerular injury while the extent of staining for mesangial cells (Table 1) . These effects are mediated by inducible NO synthase correlated positively with the cyclic AMP and by activation of protein kinase A [54] . degree of glomerular injury in the same tissue. The brain Cyclic AMP inhibits the activation of mitogen-activated form of NO synthase was not detected in normal and protein kinase (MAPK) in mesangial cells [55] . This effect nephritic glomeruli [41] .
was found to be blocked by indomethacin. The inhibitory To study the role of NO in glomerular pathology in effect on mesangial cell proliferation is mediated by the more detail, several authors analyzed production of NO by PGE2 receptor subtype EP4. Activation of the EP1 recultured mesangial cells as well as paracrine and autocrine ceptor subtype stimulates DNA synthesis in mesangial effects of NO on this cell type (Table 1) . Garg and Hassid cells [56] . The formation of PGE2 in mesangial cells is found that NO donors dose dependently inhibited cell increased by the cytokines interleukin-1-beta and PDGF replication of cultured mesangial cells which was thought [57] . The vasoconstrictors endothelin-1 and angiotensin II to be due to increased intracellular cyclic GMP [42] . also stimulate the synthesis and release of PGE2. On the Accordingly, NO donors were found to reduce angiotensin other hand PGE2 prevents the contractile effect of the II induced contraction of rat mesangial cells [43] . In vasoconstrictor angiotensin II in a dose dependent manner afferent arteriolar smooth muscle cells angiotensin II is [58] Furthermore PGE2 is able to increase the serum mitogenic and this effect is inhibited by NO [44, 45] .
m-RNA level of matrix-metalloproteinase 2 (MMP-2) Furthermore, exogenous nitric oxide inhibited mesangial [59] . In cultured rat mesangial cells MMP-2 is important cell adhesion to extracellular matrix molecules [46] . High for the degradation of collagen type IV. PGE2 not only levels of nitric oxide were found to cause apoptotic cell stimulates the degradation of extracellular matrix proteins death of rat mesangial cells [47] . Recent, Huwiler and but also reduces mRNA levels of procollagen I and III and Pfeilschifter demonstrated that exogenous NO stimulated the secretion of collagen I, III, IV and fibronectin [60] . stress-activated protein kinase [48] in mesangial cells. As Jaffer et al. demonstrated that PGE2 stimulates migration observed by immunohistochemical studies in human tissue of mesangial cells which may play a role in some forms of and experimental animals, the inducible form of NO glomerulonephritis [61] . synthase is strongly upregulated in glomerular inflamma-
The effect of prostacyclin (prostaglandin I2, PGI2) on tion both in mesangial cells as well as in macrophages.
mesangial cells was examined using beraprost-sodium, a Upregulation of inducible NO synthase is regulated by prostacyclin analog. Beraprost-sodium inhibits rat several factors including interleukin-1-beta, TNF-alpha and mesangial cell proliferation. This effect is caused by a cyclic AMP in cultured mesangial cells [49] . On the other cyclic AMP dependent induction of mitogen-activated hand, stimulation of inducible NO synthase is inhibited by protein kinase phosphatase (MKP-1) which inhibits the transforming growth factor-beta [50] , vasopressin [51] and MAP kinase pathway [62] . The function of prostacyclin is extracellular nucleotides [52] . mediated by a prostacyclin receptor (IP receptor) which is Recently, NO has been shown to play a role in regulaexpressed by mesangial cells [63] . In a rat model of tion of gene expression [53] . In human mesangial cells, crescentic glomerulonephritis, infusion of PGI2 led to a NO-donors induced upregulation of COX-2 expression for decrease in proteinuria, fibrinogen deposition and crescent up to 24 h, followed by inhibition of COX-2 expression formation [64] . This is caused by an inhibition of intragsubsequently. This effect was due to upregulation of NFlomerular coagulation and by downregulation of intercellukappa B caused by NO [53] . lar adhesion molecule-1 (ICAM-1) expression which deDue to its pleotropic effects the precise role of NO in creases leukocyte infiltration. glomerular disease is not clear at the present time. Cytotoxic effects described in several studies and promotion of glomerular hyperfiltration indicate that upregulation of NO 5. Adenosine production may be detrimental in glomerular disease. On the other hand, inhibition of mesangial cell proliferation Adenosine is a unique signaling molecule because it and reduction of platelet and leukocyte adhesion in causes vasodilation in most of the blood vessels (e.g. glomerular capillaries may represent beneficial effects peripheral arteries, coronary arteries) while it is a vasoconduring the course of glomerular disease. Because NO is a strictor in afferent glomerular arterioli of the kidney [65] . very short lived signaling molecule, space and time Formation of adenosine is the result of nucleotide breakrelationship of NO production may determine the role of down and occurs in tissue hypoxia and ischemia [66] . The NO in specific types of glomerular disease. cellular effects of adenosine are mediated by adenosine receptors which are members of the G-protein coupled receptor family [67] . The family of adenosine receptors 4. Vasodilatory prostaglandines includes four members: A1, A2a, A2b and A3 receptors. Adenosine A1-receptors have been shown to be coupled to Prostaglandin E2 (PGE2) has been shown to inhibit activation of phospholipase C and increase of intracellular 11 proliferation [54] and vasoconstriction [58] of cultured Ca , while the other three subtypes have been found to couple to cyclic AMP formation. As a result of these such as angiotensin II is found to play a detrimental role different signaling pathways, adenosine A1 receptors were accelerating the process of deterioration of renal function. found to mediate vasoconstriction while the other three Therapeutic intervention in the processes leading to endreceptors cause vasodilatation. Accordingly, A1-receptors stage glomerular disease is possible at several levels. First, have been found in afferent arteriolar vessels of the rat antiproliferative vasodilatory factors such as ANP, nitric kidney while the A2 receptor is the predominant receptor oxide or PGE2 may block mesangial cell proliferation and of the arterial vasculature of the periphery and coronary thereby exert a beneficial effect in mesangial proliferative arteries. A3 receptors have been detected in the brain and glomerulonephritis. Secondly, vasoconstriction of efferent appear to play role in neurotransmission [68] . In addition, glomerular arterioli may be reduced by vasodilatory sigadenosine has been shown to mediate tubuloglomerular naling molecules which ultimately reduce glomerular feedback in the kidney and thereby regulates glomerular hypertension and progression to glomerular sclerosis. ultrafiltration [69] . Since mesangial cells are thought to Thirdly, vasoconstriction of afferent glomerular arterioli by play a central role in the pathogenesis of glomerular adenosine may functionally counteract vasoconstriction of disease several authors examined the regulation of efferent glomerular arterioli caused by angiotensin II and mesangial cell function by adenosine (Table 1) . Cultured thereby ameliorates glomerular hypertension. Based on this mesangial cells were found to express both A1 and A2-concept, potential beneficial effects of natriuretic peptides,
receptors. In this cell type, A1-receptors stimulated Ca nitric oxide, prostaglandines and adenosine in glomerular uptake, while A2-recepors enhanced cyclic AMP accumudisease of the kidney should be examined more extensively lation [70] . In cell culture, adenosine caused mesangial cell to develop new therapeutic approaches in these diseases. proliferation and contraction by an A1-type receptor Recently, vasopeptidase inhibitors such as omapatrilat [71, 72] . Not many data are available on the regulation of were used to increase plasma levels of natriuretic peptides cultured preglomerular smooth muscle cells by extracelluto utilize potential beneficial effects of these molecules lar adenosine. In cultures of these cells, extracellular [79, 80] . In an experimental model of heart failure, omapatadenosine levels and intracellular cAMP have been shown rilat increased renal plasma flow and glomerular filtration to be dependent on the genetic background (normotensive rate after both acute and repeated dosing [80] . Moreover, vs. spontaneously hypertensive rats) and extracellular in a recent clinical trial in patients with heart failure the stimuli, e.g. isoproterenol [73, 74] . Because rat glomerular vasopeptidase inhibitor omapatrilat appeared to be more microcirculation was shown to be regulated by renal favorable than the angiotensin-converting enzyme inhibitor adenosine-1 receptors, several therapeutic approaches have lisinopril [81] . These studies indicate that increasing the been developed to utilize adenosine agonists and antagoactivity of vasodilatory factors such as natriuretic peptides nists in therapy of kidney disease [75] . Recently, highly may be a promising approach for therapy of glomerular selective adenosine-A1-receptor antagonists have been disease and chronic renal failure as well as heart failure demonstrated to exert natriuretic and diuretic actions in [82] . However, the use of vasodilatory molecules may be experimental animals [76, 77] . Currently the diuretic effect limited by side-effects such as hypotension. Additional of A1-receptor blockers is examined in congestive heart clinical trials in patients with progressive renal disease failure in humans. In a study by Poelstra et al., injection of treated with vasopeptidase inhibitors as well as the dethe adenosine analogue 2-chloro-adenosine ameliorated the velopment of new drugs which enhance activity of vasodicourse of anti-Thy 1 glomerulonephritis and reduced latory factors will ultimately clarify the potential use of proteinuria in the rat indicating a beneficial effect mediated these substances as renal protective agents. by adenosine [78] . According to the current view, reduction in proteinuria may be due to altered glomerular hemodynamics and increased afferent glomerular vasoconstriction caused by increased extracellular adenosine. It is References possible that adenosine agonists and antagonists may be useful drugs for therapy of kidney disease. 
Conclusion

